Content about Peggy Yelinek

July 16, 2012
McKesson: Seven new trends could affect medication adherence strategies

Changes in healthcare consumption, advances in technology and support from pharmacists are among seven new trends that could affect programs designed to improve medication adherence, according to a new study by McKesson.

SCOTTSDALE, Ariz. — Changes in healthcare consumption, advances in technology and support from pharmacists are among seven new trends that could affect programs designed to improve medication adherence, according to a new study by McKesson.

The company said the trends confirmed what it called the need for comprehensive adherence solutions that include technology and personalized interactions to help physicians, pharmacists and manufacturers address issues that keep patients from taking their medications as prescribed.

June 26, 2012
Q&A: Resources for overcoming the adherence challenge

Winning the patient adherence battle is about aligning all stakeholders, from the patient to the pharmacist, to payers, employers, physicians and pharma, in a collaborative, patient-centered model that not only educates patients, but also actively engages them in managing their health and treatment regimens. To find out more about how McKesson is helping community pharmacists deliver better patient care through one-on-one interventions and coaching — and get paid for it — DSN spoke Tuesday to Peggy Yelinek, VP and general manager of McKesson Patient Relationship Solutions.

Winning the patient adherence battle is about aligning all stakeholders, from the patient to the pharmacist, to payers, employers, physicians and pharma, in a collaborative, patient-centered model that not only educates patients, but also actively engages them in managing their health and treatment regimens.